Feasibility study of a novel Experimental induction protocol combining B43-PAP (anti-CD19) immunotoxin with standard induction chemotherapy in children and adolescents with relapsed B-lineage ALL: A report from the children's oncology group

Holly J. Meany, Nita L. Seibel, Mark Krailo, Doojduen Villaluna, Zhengjia Chen, Paul Gaynon, Joseph P. Neglia, Julie R. Park, Raymond Hutchinson, Judith K. Sato, Robert J. Wells, William G. Woods, Gregory Reaman

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Feasibility study of a novel Experimental induction protocol combining B43-PAP (anti-CD19) immunotoxin with standard induction chemotherapy in children and adolescents with relapsed B-lineage ALL: A report from the children's oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences